Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Stock: Nearing 52-Week Lows Amid Challenges


Pfizer's stock currently faces a challenging market position, trading precariously close to its 52-week lows. The shares recently showed minimal recovery, rising just 0.2 percent to $25.99 in New York trading. This slight uptick provides little comfort as the stock remains approximately 21 percent below its 52-week high of $31.54, though still 6.13 percent above its yearly low of $24.49. Adding to investor concerns, Pfizer insider Jennifer Damico, Senior Vice President and Controller, recently sold 2,500 shares at $25.93 each, totaling $64,825. Simultaneously, she acquired 5,583 shares through a restricted stock units program, bringing her total holdings to 11,850 shares. The pharmaceutical giant's performance reflects ongoing market challenges despite analysts setting an average price target of $30.40, suggesting significant upside potential from current levels.

Legal Issues and Dividend Appeal

Further pressuring the stock is a recent German court ruling determining that Pfizer and partner BioNTech violated Moderna's COVID-19 vaccine patent, potentially resulting in substantial compensation payments. Despite these headwinds, Pfizer maintains appeal for income-focused investors with its impressive 6.63 percent dividend yield and 55-year history of uninterrupted dividend payments. Analysts project a slight dividend increase from $1.69 to $1.70 for the current year. Following its latest quarterly results, which showed revenue of $17.76 billion and earnings per share of $0.07, experts forecast full-year 2025 earnings of $2.95 per share.

Ad

Pfizer Stock: New Analysis - 07 March

Fresh Pfizer information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Pfizer analysis...



Source StockWorld

Pfizer Inc. Stock

€20.99
-0.260%
Pfizer Inc. shows a slight decrease today, losing -€0.055 (-0.260%) compared to yesterday.
The stock is one of the favorites of our community with 21 Buy predictions and 3 Sell predictions.
As a result the target price of 31 € shows a positive potential of 47.69% compared to the current price of 20.99 € for Pfizer Inc..
Like: 0
Share

Comments